Featured Articles

Clinical Trials in Pain Research

Clinical Trials in Pain Research Marten Harbers, PhD Director Project Delivery – Early Development Services Learn more about our pain studies here. SEPTEMBER 25, 2018 Pain is one of the most common symptoms reported by patients in many therapeutic areas, making proper...

How Will Brexit Impact Pharma?

How Will Brexit Impact Pharma? Jurij Petrin, MD Senior Vice President Global Regulatory Affairs MAY 10, 2018 Brexit is currently projected to occur on 30 March 2019. Unless the UK and EU politicians find a solution to cancel or at least postpone it, after that date...

Lung Cancer Awareness Month

  Lung Cancer Awareness Month Stephen Huff Founder of The Huff Project NOVEMBER 6, 2018 Stephen Huff was diagnosed with stage IV inoperable lung cancer at the age of 29. Prior to his diagnosis, Stephen lived an incredibly healthy and clean lifestyle. As a former...

More Posts

Biologic Agents for the Treatment of Rheumatoid Arthritis

  Biologic Agents for the Treatment of Rheumatoid Arthritis Maria Victoria Hernandez MD, PhD Medical Director, Rheumatology - Medical Affairs OCTOBER 9, 2018 Rheumatoid arthritis (RA) is a chronic, inflammatory, autoimmune disease affecting around 1.5 million people...

read more

Enrollment in Cancer Clinical Trials

  Enrollment in Cancer Clinical Trials Christine Weason ACS CAN North Carolina government relations director PRA is a proud presenting sponsor of ACS CAN's ninth annual Research Breakfast, which focuses on the barriers to cancer clinical trial enrollments and efforts...

read more

Rare Disease Patient Voice

Rare Disease Patient Voice Kendall Davis Manager, Patient Advocacy & Engagement PRA will be at the 2018 RARE Patient Advocacy Summit in Irvine, California, the largest gathering of rare disease patients, advocates, and thought leaders worldwide. OCTOBER 3, 2018 The...

read more

Preparing for the Road Ahead: Rare Disease Advocates Unite

Rare Disease Advocates Unite Nicole Boice Founder of Global Genes OCTOBER 1, 2018 This year's RARE Patient Advocacy Summit takes place October 3-4 at the Hotel Irvine in Irvine, California. This annual event, hosted by Global Genes, is the largest worldwide gathering...

read more

Clinical Trials in Pain Research

Clinical Trials in Pain Research Marten Harbers, PhD Director Project Delivery – Early Development Services Learn more about our pain studies here. SEPTEMBER 25, 2018 Pain is one of the most common symptoms reported by patients in many therapeutic areas, making proper...

read more

When a Loved One Has Alzheimer’s

When a Loved One Has Alzheimer's Lindsey Jones Project Specialist SEPTEMBER 21, 2018 Alzheimer's Disease is a heartbreaking, progressive disease that destroys memory function.  Our Lindsey Jones shares her personal story about her grandmother, who had Alzheimer's....

read more

Rare Dermatology

Rare Dermatology Greg Licholai, MD Chief Medical Information Officer SEPTEMBER 20, 2018 Rare dermatological diseases are under-represented in drug development and pharmaceutical company-sponsored trials -- only about one-tenth of non-oncology rare dermatological...

read more

Obesity and Liver Damage: What is NAFLD/NASH?

  Obesity and Liver Damage: What is NAFLD/NASH? Tristan Baldwinson Senior Director, Project Delivery SEPTEMBER 19, 2018 While obesity and alcoholism are two very different health issues, both can have a similar impact on the liver. Nonalcoholic fatty liver disease...

read more

Moving Mountains for MS

  Moving Mountains for MS Chris Cardozo Help Chris meet his goal!  SEPTEMBER 13, 2018 How far would you go to help a friend? Our Chris Cardozo, a clinical research associate based in the UK, is climbing a mountain. And not just any mountain -- Mount Kilimanjaro....

read more

Clinical Care as a Care Option

  Clinical Care as a Care Option Valerie Bowling PRA is a proud corporate sponsor of this year's DPharm: Disruptive Innovations to Advance Clinical Trials conference in Boston on September 25-26. SEPTEMBER 11, 2018 Clinical research as a care option (CRAACO) is a...

read more

Updates

Neurodegenerative Research: A Future Mindset

PRA’s William Holt, DO, discusses the critical need for research into Neurodegenerative disorders, with particular emphasis on the future of clinical development and Alzheimer’s Disease research.